Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2018 February;109(1) > Minerva Medica 2018 February;109(1):53-67



Publication history
Cite this article as


A Journal on Internal Medicine

Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878




Minerva Medica 2018 February;109(1):53-67

DOI: 10.23736/S0026-4806.17.05419-2


language: English

The pathological role of the ubiquitination pathway in diabetic nephropathy

Paola PONTRELLI , Annarita ORANGER, Mariagrazia BAROZZINO, Francesca CONSERVA, Massimo PAPALE, Loreto GESUALDO

Division of Nephrology, Dialysis and Transplantation, Department of Emergency and Organ Transplantation, Aldo Moro University of Bari, Bari, Italy


Diabetic nephropathy (DN) is a chronic complication of type 2 diabetes and is the most frequent form of chronic kidney disease that can lead to end-stage renal disease. Different pathways, involved in oxidative stress, inflammation, fibrosis and cell death, are responsible for the pathogenesis of DN and regulate the progression of the disease. Ubiquitination is a fundamental pathway in intracellular signaling whose role is emerging in the regulation of molecular processes responsible for several human diseases. Among the conventional ubiquitination pathway, leading to proteasomal degradation of proteins, also non-conventional ubiquitination plays an important role in the regulation of intracellular signaling. Several proteasome inhibitors have been developed and tested both in humans and in animal models and show potential as promising therapeutic approaches. In this review, we focused our attention on the role of ubiquitination pathway in the principal processes involved in the pathogenesis and progression of DN.

KEY WORDS: Diabetic nephropathies - Ubiquitination - Diabetes mellitus

top of page

Publication History

Issue published online: December 4, 2017
Article first published online: October 3, 2017
Manuscript accepted: September 25, 2017
Manuscript received: September 8, 2017

Cite this article as

Pontrelli P, Oranger A, Barozzino M, Conserva F, Papale M, Gesualdo L. The pathological role of the ubiquitination pathway in diabetic nephropathy. Minerva Med 2018;109:53-67. DOI: 10.23736/S0026-4806.17.05419-2

Corresponding author e-mail